By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor To Present At Two Upcoming Conferences In December 11/24/2015 7:31:13 AM
Xencor Presents Data On Xmab5871 Program At American College of Rheumatology 2015 Annual Meeting 11/9/2015 8:23:23 AM
Preclinical Data Of Xencor's XmAb Bispecific Technology To Be Presented At Upcoming American Society of Hematology Annual Meeting 11/6/2015 6:33:09 AM
Xencor To Present At Credit Suisse 24th Annual Healthcare Conference 11/4/2015 10:30:46 AM
Xencor Reports Third Quarter 2015 Financial Results And Pipeline Update 11/4/2015 7:54:54 AM
Xencor To Host Third Quarter 2015 Financial Results Webcast And Conference Call On November 3, 2015 10/27/2015 12:11:13 PM
Xencor To Present At Leerink Partners Inaugural Immuno-Oncology Roundtable 9/25/2015 12:12:48 PM
Xencor's Partner Initiates Phase 2 Clinical Trial Of A Biologic Candidate Using XmAb Cytotoxic Fc Domain 9/24/2015 11:26:52 AM
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones 9/16/2015 5:54:39 AM
Xencor Reports Second Quarter 2015 Financial And Operating Results 8/5/2015 6:58:30 AM